| P50 | author | Murray Grossman | Q66724764 |
| P2093 | author name string | Lauren Massimo | |
| P2860 | cites work | Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q22241632 |
| | “Mini-mental state” | Q25938989 |
| | Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 |
| | Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 |
| | Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 |
| | Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease | Q28756699 |
| | Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 |
| | Neurodegenerative tauopathies | Q29619895 |
| | Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. | Q30351745 |
| | Tube feeding in patients with advanced dementia: a review of the evidence | Q33754676 |
| | A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory | Q33886358 |
| | The FAB: a Frontal Assessment Battery at bedside. | Q33927821 |
| | The prevalence of frontotemporal dementia | Q33959615 |
| | Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration | Q33999208 |
| | Is there a role for 5-HT1A agonists in the treatment of depression? | Q34174041 |
| | Clinicopathological correlates in frontotemporal dementia | Q34345893 |
| | High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands | Q34388804 |
| | Anatomical correlates of early mutism in progressive nonfluent aphasia | Q34570333 |
| | Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. | Q34573456 |
| | New developments in frontotemporal dementia and parkinsonism linked to chromosome 17. | Q34769187 |
| | Frontotemporal dementia: genetics and genetic counseling dilemmas | Q35873891 |
| | Oops! Resolving social dilemmas in frontotemporal dementia | Q36227359 |
| | Assessment and management of chronic pressure ulcers in the elderly | Q36590019 |
| | Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17 | Q36637691 |
| | Frontotemporal lobar degeneration: recent progress in antemortem diagnosis | Q36836747 |
| | Frontotemporal dementia: clinicopathological correlations | Q37069848 |
| | Methylphenidate treatment of negative symptoms in patients with dementia | Q41465137 |
| | Clinical and pathological evidence for a frontal variant of Alzheimer disease | Q41696080 |
| | Rivastigmine in frontotemporal dementia: an open-label study. | Q42641006 |
| | Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study | Q44237719 |
| | Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. | Q44687049 |
| | Frontotemporal dementia: a randomised, controlled trial with trazodone | Q44922723 |
| | Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia | Q46047796 |
| | Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. | Q46920843 |
| | Familial aggregation in frontotemporal dementia | Q47951956 |
| | The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene | Q48384348 |
| | Assessing resource demands during sentence processing in Parkinson's disease | Q48660545 |
| | Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics | Q48661008 |
| | The genetic and pathological classification of familial frontotemporal dementia | Q48712044 |
| | Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease | Q48913788 |
| | Antemortem diagnosis of frontotemporal lobar degeneration | Q48957288 |
| | A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia | Q49160901 |
| | The correlation of cognitive decline with frontotemporal dementia induced annualized gray matter loss using diffeomorphic morphometry. | Q50773336 |
| | Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study. | Q50793970 |
| | Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. | Q51969863 |
| | Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. | Q52011967 |
| | Valproic acid treatment of agitation in dementia. | Q53958469 |
| | Frequency oftau mutations in three series of non-Alzheimer's degenerative dementia | Q57306412 |
| | Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia | Q73632005 |
| | Frontotemporal dementia | Q79355717 |
| | Limb apraxia in corticobasal degeneration and progressive supranuclear palsy | Q81378451 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 125-131 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | American Journal of Alzheimer's Disease & Other Dementias | Q4744232 |
| P1476 | title | Patient care and management of frontotemporal lobar degeneration | |
| P478 | volume | 23 | |